Emery N. Brown
Massachusetts Institute of Technology
Francis J. Doyle
Harvard University
S. Chakravarty
Alexion Pharmaceuticals (United States)
Harshith Padigela
SignPath Pharma (United States)
Ilan Wapinski
Critical Path Institute
Amaro Taylor‐Weiner
PathAI (United States)
Benyamin Meschede-Krasa
Stanford University
Elizabeth B. Klerman
Massachusetts General Hospital
Marcus A. Badgeley
Tempus Labs (United States)
Andrew H. Beck
Stanford University
PathAI (United States)
Critical Path Institute
Harvard University
University of Miami
SignPath Pharma (United States)
Colorado State University
International Association for the Study of Lung Cancer
Massachusetts General Hospital
Massachusetts Institute of Technology
Faculty of 1000 (United States)